secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2022-07-11T23:59:59+00:00
Accession:  0001193125-22-191340
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chief Medical Officer Chris Morabito resigns effective July 13, 2022
--------------------------------------------------------------------

- Chris Morabito, M.D., stepped down as Chief Medical Officer of Fulcrum Therapeutics.
- Resignation effective July 13, 2022; he left to pursue another opportunity.
- No replacement announced; departure not due to any disagreement with company.
- Morabito's resignation follows no known operational or financial disputes.
- Fulcrum did not provide details on interim CMO or search timeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/0001193125-22-191340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/d338706d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-191340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer